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Glass type Starting Reaction Reaction product Detection Method
pH time
(days)
Reaction in 1M K2HPO4 Solution
45S5B1 7 5 HAp XRD, IR
45S5c 7 35 HAp IR
Reaction in 0.1M K2HPO4 Solution
45S5B1 7 14 HAp XRD, IR
45S5c 7 28 HAp XRD, IR
Reaction in 0.01M K2HPO4 Solution
45S5B1 7 1 1 2 Amorphous Ca-P XRD, IR
45S5c 7 1 1 2 Amorphous Ca-P XRD, IR
Reaction in 0.001M K2HPO4 Solution
45S5B1 7 1 1 2 Amorphous Ca-P XRD, IR
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FIELD OF THE INVENTION
This invention relates to materials having the capacity to 
form a calcium phosphate (CaP) layer thereon. These mate­
rials are ceramic, glass, glass-ceramic or partially crystalline 
and are bioactive in that they are osteoconductive, osteo- 
stimulatory or osteogenic nature when contacted with physi­
ologic solutions, including mammalian bodily fluids and 
tissues. This invention also provides rapid methods of pro­
ducing CaP (Hydroxyapatite (HAp) and amorphous HAp) 
on the surface of a bioactive material.
BACKGROUND OF THE INVENTION
Certain prior ceramic compositions, especially glass and 
glass-ceramic, are known to support the bonding, growth or 
genesis of bone by fostering a supportive environment 
between the material and living, bone progenitor cells. It is 
widely recognized that successful bioactive glasses include 
silica in order to foster the needed supportive environment. 
These compositions are considered bioactive since they 
possess surfaces capable of fostering a calcium phosphate 
layer which, in turn, promotes bone bonding to the material. 
Bioactive materials of the type described herein include 
surface-active materials such as those disclosed in U.S. Pat. 
No. 5,204,106, Schepers, et al., termed 45S5 glass which are 
of the composition Na20.Ca0P20 5.Si02.
When implanted, bone formation has been observed in 
45S5 as occurring throughout the entire defect through 
osteogenesis via osteostimulation, assisted by osteoconduc- 
tion due to the calcium phosphate layer that is formed prior 
to the central, cellular mediated disintegration. As used 
herein, osteoconduction generally means the apposition of 
growing bone to the three dimensional surface of a suitable 
scaffold provided by a graft. Osteogenesis, as used herein, 
generally means the process of bone formation through 
cellular osteoblastic activity. Osteostimulation, as used 
herein, generally means the promotion of bone growth. 
Upon central disintegration, the bioactive glass particles are 
fully transformed into calcium phosphate. The composition 
and size of the preferred granules in Schepers et al., are such 
that the particles are gradually transformed as the defect site 
becomes vascularized and populated with bone tissue­
forming cells.
Kokubo et al., “Chemical Reaction of Bioactive Glass and 
Glass-Ceramics with a Simulated Body Fluid,” J  Mater. 
Sci.: Mater. Med 3, 79-83 (1992), among others, have 
described the need for a hydroxyapatite layer to promote 
bone bonding since hydroxyapatite, whose stochiometric 
composition is Ca10(PO4)6(OH)2, is the major inorganic 
component of living bone. It is biocompatible with hard and 
soft tissues when used as implants. The crystallinity of HAp 
varies with the maturity of the bone, can contain carbonate, 
and can be calcium or phosphate deficient.
The drive to form hydroxyapatite on glass materials led 
Hench and others to use 45S5 glass as a starting material (L. 
L. Hench, R. J. Splinter, T. K. Greenlee, and W. C. Allen, 
“Bonding Mechanisms at the Interface of Ceramic Pros­
thetic Materials,” J  Biomed Mater. Res. Symp. 117-141 
(1971)). The theory of apatite formation was extensively 
explained through the necessary steps of the formation of a 
hydrated silica gel layer inducing and promoting the nucle- 
ation of apatite. When alkali silicate glasses dissolved, alkali 
ions at the glass surface were selectively exchanged for 
hydronium ions in the surrounding solution, leaving a
hydrated silica gel layer, which served as a nucleation site 
for CaP crystal deposition, and then subsequent dissolution. 
Thereafter, most glass compositions used for bioactive pur­
poses contained from 30 to 60 Wt. % Sio2, since it was 
widely accepted that the formation of hydroxyapatite would 
occur on particles with a silica-rich layer.
Neo et al., “Difference in Ceramic-Bone Interface 
Between Surface-Active Ceramics and Resorbable Ceram­
ics; A Study by Scanning and Transmission Electron 
Microscopy,” J. Biomed. Mater. Res., 26, 255-267 (1992), 
recognize that surface active glasses and glass ceramics 
bond to bone through an intervening hydroxyapatite layer. 
When in contact with bodily fluids, the surface of the silicate 
glass is transformed into a silica-rich layer onto which 
calcium and phosphorus ions from the surrounding fluids 
precipitate as a calcium phosphate hydroxyapatite layer. 
This intervening hydroxyapatite layer is free of collagen and 
composed of fine granular apatite crystals distinct from 
those of bone.
The process of synthesizing hydroxyapatite is often time 
consuming. Processes such as precipitation, hydrolysis, or 
the use of sol gel usually require several steps over several 
weeks to form hydroxyapatite, and yet, stochiometric 
hydroxyapatite cannot be achieved easily. Even 45S5, which 
provides a surface for the formation of HAp, have in vivo 
reactions that occur slowly prior to fully bonding to bone. 
There are few alternative ceramic compositions that are 
capable of supporting bone growth without silica playing a 
critical role in the formation process.
Bioactive glasses have been very successful in the pro­
motion of bone growth via a HAp layer, but there are 
problems. By enlarging the range of starting materials, the 
drawbacks found in present materials such as those relying 
chiefly on the presence of silica, may be avoided. Alternative 
starting materials such as those containing borate may also 
produce HAp at a faster rate.
Accordingly, it is the object of this invention to provide 
alternative bioactive materials that are bioactive when used 
in vivo.
It is also the object of this invention to provide more rapid 
methods for producing CaP on a bioactive glass.
Additional objects, advantages and novel features of this 
invention will become apparent to those skilled in the art 
upon examination of the following descriptions, figures and 
claims thereof, which are not intended to be limiting.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows a graph of reaction layer growth on 45B5-1 
glass spheres in 1 M phosphate at different temperatures. 
These measurements are each the average of six spheres. 
Full reaction of the spheres occurred in 24, 18, and 4 hours 
at 37° C., 47° C., and 57° C., respectively.
FIG. 2 shows the X-Ray diffraction (XRD) patterns of A) 
well crystallized HAp, B) synthetic HAp, C) the inorganic 
component of bone and D) 45B5-1 reacted with 1 M 
phosphate solution for 24 hours at 37° C.
FIG. 3 is a table depicting a summary of reactions of 
45S5c (partially crystallized 45S5) and 45B5-1 glass spheres 
in lydPC ^ solutions.
FIG. 4 shows the XRD patterns of 45B5-1 glass spheres 
75 to 150 pm  in diameter reacted with 1 M (A) and 0.1 M 
(B) solution at 37° C., initial pH=7. The main HAp peaks are 
marked with arrows and indicated by the lines at the bottom 
of each figure.
FIG. 5 shows the XRD patterns of 45B5-1 glass spheres 
















initial pH=7. Only a weak HAp XRD pattern appears after 
112  days of reaction (16 weeks).
FIG. 6 depicts the appearance of hydroxyapatite crystals 
on the surface of 45B5-1 glass spheres reacted for 1, 4, 11, 
and 26 days in a 1 M K2HP0 4 solution at 37° C. of starting 
pH of 7 (respectively A, B, C and D).
FIG. 7 depicts the appearance of the surface of 45B5-1 
glass spheres (A) and the surface underneath the plate layer 
(B and C) reacted for 16 weeks (112 days) in a 0.001 M 
K2HP04 solution at 37° C. of starting pH of 7.
FIG. 8 shows 45B5-1 glass microspheres immersed in 1 
M Na2HP04 solution at 37° C. at initial, 6 hour, 18 hour and 
24 hour times. The bubbles shown in the initial frame are a 
result of flame spheroidization.
FIG. 9 depicts XRD patterns of 45B5-1 reacted with 1 M 
phosphate for 1, 4, and 1 1 days, and the documented XRD 
pattern for Hap.
FIG. 10 shows 45B5-1 glass microspheres, after immer­
sion in 1 M Na2HP04 solution for 24 hours at 37° C., which 
were subsequently mounted in polymethyl methacrylate 
(PMMA) and cross-sectioned. The cavities or dark spots 
inside the microspheres are gas bubbles formed during 
spheroidization.
FIG. 11 depicts surface apertures of 45B5-1 (A and B) 
glass spheres reacted in 1 M lydPC ^ solutions for 5 days).
FIG. 12 depicts a cross section of a rat tibia containing 
45B5-1 glass particles implanted for 15 days in vivo. The 
black lines denote the edges of the initial hole. New bone 
(shown by black arrows) has formed on the edge of the holes 
and around the particles, but the holes are still open.
FIG. 13 depicts a cross section of a rat tibia containing 
45B5-1 glass particles after 30 days in vivo. The particles of 
45B5-1 are surrounded by new bone and the original holes 
are sealed.
SUMMARY OF THE INVENTION
Notwithstanding its inexhaustible embodiments, the 
invention is bioactive materials having the formula 
xNa20.yCa0.zP20 5.qB20 3 wherein x is from about 20% to 
about 35% by weight; y is from about 20% to about 35% by 
weight; z is from about 0% to about 10% by weight; and q 
is from about 30% to about 50% by weight. The bioactive 
materials can be ceramic, glass, glass-ceramic or a crystal­
line material. Many embodiments have a calcium phosphate 
surface layer upon the bioactive material and in others, the 
calcium phosphate layer is hydroxyapatite. The invention 
also forms a calcium phosphate layer when in contact with 
a physiological solution. In preferred embodiments, x is 
22.9%, y is 22.9%, z is 5.6% and q is 48.6%. The invention 
can also take the form of particles that have a particle size 
range from about 1 fim to about 400 fim. Preferably, the 
range can be from about 40 fim to about 300 fim, or 60 fim 
to about 250 fim. More preferably the range can be from 
about 75 fim up to about 1 mm. The invention can be 
generally spherical, morselized, in coating form or in bulk. 
The invention can also be fibrous or foliaceous.
The invention is a particulate borate ceramic, the particles 
of the ceramic being at least a partial calcium phosphate 
layer thereupon.
This invention is also a process for providing a bioactive 
material comprising reacting a material having the formula 
xNa20.yCa0.zP20 5.qB20 3 with an aqueous solution com­
prising phosphate ions for a time sufficient to dispose CaP 
upon said material. The aqueous solutions used in the 
process can be Na2HP04 or K2HP04 with concentrations
3
ranging from about 0.001 M to about 1 M. Preferably, the 
concentration is about 0.1 M or about 0.01 M. More 
preferably, the concentration is about 1 M. The phosphate 
solutions have an initial pH in the range of about 6 to about 
10.
While providing faster methods for producing CaP on 
bioactive glasses, the invention can be conducted in a 
temperature range of about 30° C. to about 60° C. 
Preferably, the temperature range is about 35° C. to about 
57° C. In another embodiment, the reaction takes place at a 
constant temperature of about 37° C. The process features a 
flexible reaction time from about 4 hours to about 2 weeks. 
The reaction time period can be about 5 days to about 14 
days. A preferable time for the reaction is between about 4 
hours to about 24 hours. In some embodiments the reaction 
time can be about 24 hours.
Certain embodiments of this invention provide bioactive 
ceramic materials comprising borate glass that possess a 
calcium phosphate layer. As used herein, borate glass refers 
to a m aterial having a general com position of 
Na20.Ca0P20 5.B20 3 in some embodiments. 45B5-1 borate 
glass embodies certain aspects of this invention having the 
aforementioned composition. Typical embodiments of this 
invention are a ceramic material wherein Na20  is from 
about 20% to about 35%; CaO is from about 20% to about 
35%; P20 5 is from about 0% to about 10%; and B203 is from 
about 30% to about 50%. In more typical embodiments 
Na20  is from about 22% to about 30%, CaO is from about 
22% to about 30%, P20 5 is from about 5% to about 6%, 
B203 is from about 35% to about 50%. The ranges disclosed 
herein include all combinations and subcombinations of 
ranges and specific percentages therein. In some preferred 
embodiments, there is about 22.9% Na20 , about 22.9% 
CaO, about 5.6% P20 5 and about 48.6% B203. The per­
centages disclosed herein are meant to include the percent 
composition by weight. In other embodiments, it is foresee­
able that the borate glass material can contain Li20  or K20.
As used herein, ceramic is considered all materials that 
are inorganic, nonmetallic solids. They can be metal oxides 
but many ceramics are also compounds of metallic elements 
and carbon, nitrogen, or sulfur. In atomic structure they are 
most often crystalline, although they also may contain a 
combination of glassy and crystalline phases. As used 
herein, glass is considered a non-crystalline inorganic solid 
material that can be transparent or translucent as well as hard 
and brittle. As used herein, glass-ceramic is considered a 
glass with crystalline components.
Typical embodiments of the invention are at least partially 
crystalline. 50% to 80% of the material may be crystalline. 
In other embodiments 30% to 50% may be crystalline and in 
more typical embodiments, less than 30% to less than 1% 
can by crystalline.
The invention provides a bioactive ceramic that is pre­
reacted to give a calcium phosphate layer disposed upon the 
ceramic. This layer is a hydroxyapatite layer in some 
embodiments that may be preferred. The formation of the 
HAp layer on the borate glass of the present invention may 
be formed by reacting the glass with phosphate ions and is 
related to the pH change of the solutions that harbor the 
glass. The pH of solutions that interact with the borate 
ceramic display a general increase within the first two 
weeks. This is likely due to the high (25 mol %) alkali 
content of the material, which in turn increases solution 
alkalinity. It is generally observed that the final pH increases 
by 1.5 to 3 units in solutions of 0.1 M phosphate and lower. 
















material. Initially, sodium ions in the ceramic are replaced 
with hydrogen ions from solution to form hydroxyl groups. 
These hydroxyl groups react with the structural bonds 
between boron and oxygen, setting the boron ions free. As 
the ion exchange proceeds into the bulk of the ceramic, there 
is an increase in the surface area of the ceramic and 
dissolution occurs/proceeds from the surface inward. The 
pH of the solution eventually stabilizes since the ion con­
centration gradient (potential for exchange of ions between 
the solution and the glass) reaches steady state. Precipitation 
of a layer of calcium phosphate occurs from the ionic 
reaction between calcium and phosphate within the ceramic 
and in the solution. Over a number of days, the thickness of 
this precipitated surface layer increases.
General embodiments of the invention include a particu­
late borate ceramic, the particles being at least a partial 
calcium phosphate layer thereupon. The particles are gen­
erally found in a crushed state, 300 fim to 355 fim approxi­
mate size range. Embodiments can have a general diameter 
ranging from about 1 fim to about 1 mm, or 40 fim to about 
400 fim. Preferably, the diameter range is about 60 fim to 
about 250 fim with 75 fim to about 150 fim being the most 
preferred. As used herein, the diameter range is measured by 
standard techniques including scanning electron microscopy 
(SEM) photos that had a calibrated length scale and using 
sieves of known openings.
The ceramic material can also come in the form of 
microspheres, morsels, fibers, flakes or even in bulk. It is 
appreciated that since the diameter range may vary, the 
shape of glass particles will also vary in their microspherical 
form. Therefore, their shape may be generally spherical. If 
the glass is not spheroidized but left in a crushed state, it is 
considered to be in morsel form. As used herein, the folia- 
ceous shapes are considered those shapes having leaflike or 
flake-like structures. As used herein, the fibrous shapes are 
considered those structures having, consisting of or resem­
bling fibers. As used herein, bulk forms are considered those 
that encompass a variety of shapes or forms in a large 
volume or mass. The material may also be used as a coating 
for other materials suitable for implantation within the body.
A subset of embodiments of this invention includes meth­
ods for making a bioactive glass material are provided. A 
material having the formula Na2O.CaO.P2O5.B2O3 is 
reacted with an aqueous solution comprising phosphate ions 
for a time sufficient to form calcium phosphate upon said 
material. Solutions comprising phosphate ions used in many 
preferred embodiments of this invention include Na2HP04 
and K2HP04. In other embodiments, acids containing phos­
phate ions, such as H3P 04, are reacted with the material.
In one embodiment, a HAp layer can be formed on the 
surface of 45B5-1 glass particles when reacted in aqueous 
phosphate ion solutions within a general range of 0.001 M 
to 1 M and all combinations and subcombinations of ranges 
and specific concentrations therein concentrations at 37° C. 
and starting pH of 7. The rate of formation is more apparent 
at 0.1 M and 1 M wherein formation occurs from 14 days to 
as few as 5 days, respectively. The rate of formation is 
slower for phosphate solutions of lower concentrations 
within a general range of 0.001 M to 0.01 M and all 
combinations and subcombinations of ranges and specific 
concentrations therein. However, the slower rates of the 
latter concentrations may be more favorable depending on 
the aims of the procedure for which the ceramics are being 
used.
The reaction can occur at constant temperatures generally 
within the 30° C. to 60° C. range and all combinations and
5
subcombinations of ranges and specific temperatures 
therein. Formation of HAp on the material of the invention 
occurs within a range of 24 to 4 hours and all combinations 
and subcombinations of ranges and specific times therein 
when reacted in a 1 M aqueous phosphate solution at 
temperatures ranging from 37° C. to 57° C. (FIG. 1). At 
other concentrations, reaction time can vary from 4 hours to 
2 weeks. At 0.1 M and 1 M, HAp can form at 37° C., the 
preferred temperature for the production of an implantable 
bioactive glass material, in 14 and 5 days, respectively. The 
time needed to produce an adequate layer of HAp varies 
with changes in the temperature of the reaction and/or the 
concentration of the phosphate solution. It is appreciated 
that there are circumstances when these variables can be 
altered for the specific purposes of the producer.
According to certain embodiments of this invention, the 
HAp on the ceramic enables the bioactive material to mimic 
the natural bone processes of osteoconduction, osteogenesis, 
and osteostimulation. The bioactive material of the many 
embodiments of this invention is rendered osteoconductive, 
osteostimulatory, or osteogenic when contacted with mam­
malian bodily fluids.
Certain embodiments of this invention demonstrate a 
lower melting temperature and a broader range of solubility 
when compared with 45S5 (melting temperatures 1300° 
C.-14000 C.). Absent also are any of the physiologic con­
cerns that may be associated with having silica. Certain 
embodiments of this invention are impenetrable to X-rays 
and are therefore radiopaque, which has important medical 
implications, since it is often necessary or desirable to 
visualize the material once implanted (in vivo).
Under in vivo conditions, the reaction of the bioactive 
particles occurs through the uniform continuous leaching of 
Na+, B+3 and Ca30 2 from the ceramic. It has been deter­
mined that there is no shrinkage of the particles during the 
reaction of the material in Na2HP04 solution or in simulated 
body fluids. Further, HAp formation on the surface of 
45B5-1 has similar crystal shape, size and degree of crys­
tallinity as natural bone when reacted with phosphate solu­
tions. FIG. 2 shows the XRD pattern of the inorganic 
component of bone, synthetic HAp, well-crystallized HAp 
and 45B5-1 microspheres reacted with 1 M phosphate 
solution for one day at 37° C. The XRD pattern of 45B5-1 
reacted with 1 M phosphate solution for 24 hours at 37° C. 
(FIG. 2D) is quite similar to the patterns for natural bone 
(FIG. 2C) and synthetic HAp (FIG. 2B), which indicates that 
the degree of crystallinity of the reacted 45B5-1 is close to 
natural bone. The shape and size of HAp crystals are also 
similar in the reacted 45B5-1 microspheres and living bone.
HAp formation is observed on XRD patterns of 45B5-1 
after 1, 4, and 11 days in Na2HP04 solution. IR spectra 
confirm the presence of HAp structures on the reacted 
ceramic. ICP analysis demonstrates the decrease in the 
amount of phosphorus and the total absence of calcium in 
the reacting solution after 80 days. The ICP results indicate 
that the phosphorus combines with the calcium from the 
glass to form HAp. SEM combined with EDS has estab­
lished the presence of calcium and phosphate on the surface 
of the 45B5-1 spheres reacted in phosphate ion solutions 
ranging from 0.001 M to 1 M.
The invention is further unique in that it fosters the growth 
of CaP and is bioactive while being substantially free of 
silica. As used herein, substantially silica-free means less 
than 10% silica in some embodiments, fewer than 5% in 
others, and less than 2% in many. In more typical 
















which will not interfere with the basic functions of this 
invention. In some embodiments that may be preferred, the 
invention contains only a trace of silica amounting to less 
than 0.25% by weight.
According to the ICP data, a uniform dissolution process 
of borate spheres that are silica-free occurs in aqueous 
phosphate solutions. In these phosphate solutions, a uniform 
dissolution releases all the sodium and phosphorous ions 
contained in the borate glass system without forming a 
borate gel. The absence of such a gel greatly lowers the 
interaction of the particles with the surrounding liquids, 
leading to a lower viscosity of the solid liquid suspension 
and a free flowing of the particles with body fluids. The 
calcium phosphate combines and freely precipitates on the 
surface of the glass spheres without the need for a silica gel 
nucleating agent, which was once believed necessary to 
foster bone growth on glass material.
The substantially silica-free borate glass materials 
embodied in this invention react faster when compared to 
the reaction kinetics of 45S5 glasses. The formation of a 
crystalline HAp layer on the 45S5 silicate glasses depends 
on several variables including the rate of ion exchange, 
hydroxylation of the glass surface and pH and ion concen­
tration of the solution. XRD data shows a crystalline HAp 
pattern in 28 days for partially crystallized 45S5 glass 
spheres reacted in 0.1 M solution of starting pH of 7, 
whereas, it takes only 14 days for HAp to appear in the XRD 
pattern for silica-free borate glass reacted in the same 
solution. FIG. 3 shows the reaction products of 45S5c and 
45B5-1 in phosphate solutions of varying molarity.
Unlike 45S5 glasses, the rate of formation of HAp on the 
surface of the bioactive borate ceramic of the present inven­
tion can occur within as few as 5 days. This is a result of the 
generally lower chemical durability of borate ceramic when 
compared to silicate glass, which in turn affects the rate of 
dissolution of the borate ceramic. Borate ceramics of the 
present invention tend to dissolve more uniformly/ 
consistently since the dissolution rate of borate ceramic is 
controlled by bulk dissolution instead of the dissolution of a 
single species within the ceramic. Further, since no silica is 
present in the borate ceramic, no potentially problematic 
(biocompatibility-wise) silica layer is formed during the 
dissolution process. Additionally, borate ceramics can be 
formed at lower temperatures-lower melt/processing tem­
peratures. In vivo, bone growth around bioactive borate 
ceramic particles is faster than the growth associated with 
silicate glass particles implanted under similar conditions.
EXAMPLES
Example—1
Glass Particle Preparation and Pre-Reaction Process
45B5-1 borate glass of composition of 48.6% B20 3 22.9% 
CaO, 22.9% Na20 , and 5.6% P20 5 Wt % was prepared 
using H3BO3, CaC03, Na2C 03, and Na2HP04 (Fisher 
Scientific, St. Louis, Mo.). The raw materials were mixed 
and melted at 1100° C. in a platinum crucible for an hour. 
The melt was quenched between two room temperature 
stainless steel plates and then immediately annealed in an 
electrical furnace at 450° C. for three hours and cooled 
overnight. The borate glass was crushed and sieved to 
recover particles in the 300-355 micron size range, which 
were used for implantation.
Particles in the size range of 75-200 fim were sphe- 
roidized at 1000° C. The spheres were sieved to separate
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those in the 75-150 fim size range, which were used for 
experimentation. Other irregular particles in the size range 
of 45-75 fim were also used.
The spheres were produced in a vertical, electrically 
powered tube furnace. A hot zone, 127 cm in length, was 
sufficient to spheroidize the borate glass particles at 1000° C. 
The particles were dropped into the top of the furnace tube 
and the spheres collected at the bottom of the furnace tube 
in a glass jar. The tube was tightly sealed to prevent chimney 
effect, convection currents, in the tube. The annealing tem­
perature of the glass was determined using differential 
thermal analysis (DTA). The spheres were annealed at 450° 
C. for an hour and cooled to room temperature.
The density of the glass particles and spheres was mea­
sured by a standard picnometer procedure using ethanol. The 
density measured for the 45B5-1 spheres and particles was 
around 2.16±0.2. The density indicated that the spheroidiza- 
tion process did not change the final density between glass 
particles and spheres.
DTA and Thermo-Gravimetric Analysis (TGA) were per­
formed on 45B5-1 glass using a Netzsch STA 409 at a 
heating rate of 15° C. per minute in air. These techniques 
were used to determine the glass transition temperature and 
weight loss on heating from 22° C. to the melting tempera­
ture.
The onset of crystallization for the 45B5-1 glass occurred 
at 572° C.±5° C. and subsequent melting was found at 864° 
C.±2° C. (The glass transition temperature for the 45B5-1 
glass was determined to be around 505° C.±5° C.) Little 
measurable weight loss of 0.03 wt % was observed over a 
temperature range of 1 00° C. to 1150° C.
To produce a layer of HAp on the surface of the particles, 
the 45B5-1 glass particles were reacted for 24 hours in a 1 
M Na2HP04 solution with a starting pH of 7 at 37° C. The 
phosphate solution was prepared by dissolving the appro­
priate amount of reagent grade Na2HP04 (Fisher Scientific, 
St. Louis, Mo.) in distilled water acidified with 1.5 M HC1. 
After complete dissolution of the Na2HP04, the pH was 





Partially crystallized 45S5 glass spheres, hereinafter 
referred to as 45S5c, and 45B5-1 glass spheres were reacted 
in K2HP04 solutions at a constant temperature of 37° C. The 
45S5c glass was reacted in solutions of 1, 0.1, 0.01, and
0.001 M K2HP04 at a starting pH of 7, 8 and, 9.5. The 
45B5-1 glass was reacted in solutions of 1, 0.1, 0.01, and 
0.001 M K2HP04 at starting pH of 7.
The phosphate solutions were prepared in glass beakers 
by dissolving the appropriate amounts of l^HPC^ reagent 
grade in distilled water. The pH was monitored and adjusted 
with HC1 to obtain the desired starting pH value. The HC1 
used was diluted with distilled water to a concentration of 
about 14%. The phosphate solutions were stored at a con­
stant temperature of 37° C.
XRD Investigation of Hydroxyapatite Formation
1 M K2HP0 4 solutions. The XRD pattern of FIG. 4A 
shows that the formation of hydroxyapatite upon 45B5-1 
glass spheres reacted in 1 M ly/lPC^ solution occurs in as 
few as 5 days at 37° C. The main XRD peaks of the pattern 
obtained after 5 days of reaction matches closely the 20 


















0.1 M K2HP04 solutions. The XRD pattern of FIG. 4B 
shows that the formation of FIAp occurs in as few as 14 days 
for the 45B5-1 glass reacted in 0.1 M K2HP04 solution at 
37° C. No further change in the XRD pattern is observed 
with further reaction of the spheres up to 35 days in the 0.1 
M solution. The XRD pattern shows strong diffraction peaks 
for hydroxyapatite for the borate glass spheres reacted in the 
0.1 M K2HP04 solution.
0.01 M and 0.001 M KdlPO,, solutions. The XRD 
patterns of 45B5-1 glass spheres reacted with 0.01 M and 
0.001 M phosphate solutions show the formation of poorly 
crystalline HAp. FIGS. 5Aand 5B show the XRD spectra for 
45B5-1 glass spheres reacted in 0.01 M and 0.001 M 
phosphate solutions at a starting pH of 7 at 37° C., respec­
tively. The XRD pattern of 45B5-1 glass reacted in the 0.01 
M solution after 2 weeks shows only a low intensity, diffuse 
split peak indicated by arrows around 32° to 34° (20). The 
XRD pattern seemed unchanged between 2 to 16 weeks for 
the glass spheres reacted in the 0.01 M phosphate solution. 
The XRD pattern of the 45B5-1 glass reacted for up to 9 
weeks in the 0.001 M solution slowly changes towards the 
low intensity and diffuse split peak mentioned above and 
indicated by arrows in FIG. 5B. After 9 weeks, the XRD 
pattern remains unchanged with further reaction up to 16 
weeks.
SEM Investigation
The SEM observations of samples of borate spheres 
reacted in 1 M K2HP04 solution for 1, 4, 11 and 26 days 
show the presence of a HAp microstructure (FIG. 6). The 
external surface of a reacted sphere is covered with a 
platelike structure at day 1 (FIG. 6A). These small plates, 
arranged perpendicular to the surface of the glass, homoge­
neously cover the entire surface of the reacted spheres at 
days 4 and 11 (FIGS. 6B and 6C). At day 26 (FIG. 6D), the 
plates have completely covered the surface of the spheres 
obstructing the little porosity that remained at day 11. The 
outer layer covering the glass spheres seems to form a 
impermeable layer that might slow down further bulk dis­
solution reaction of the glass with the solution, but according 
to the IR spectra and XRD diffraction pattern at 26 days of 
reaction, 45B5-1 glass spheres have already formed a fully 
crystalline HAp.
The reaction layer formed at days 1 and 4 with platelike, 
fine structures is more or less ordered and forms a porous 
structure. EDS revealed the presence of calcium and phos­
phorus with a Ca/P ratio of 1.42±0.5 in contrast with the 
HAp stochiometric Ca/P ratio of 1.67. (The platelike par­
ticles about 50 microns across on the surface of 45B5-1 glass 
spheres reacted in 1 M solution do not seem to increase in 
size between 1 and 26 days.) The stability in the size of the 
particles between 1 and 26 days indicates that the formation 
of calcium phosphate particles on borate glass spheres 
reacted in a 1 M I^HPC^ solution is a uniform and rapid 
process that occurs in one day. The same platelike micro­
structure was observed on 45B5-1 borate glass spheres 
reacted for one day in a 0.1 M K2HP04 solution.
Borate glass spheres reacted in the 0.01 M K2HP04 
solution for 16 weeks (FIG. 7) also exhibit a platelike, 
porous microstructure. The platelike structure observed on 
the sample reacted in 1 M and 0.1 M solution is still present 
on one of the spheres but a somewhat different morphology 
is generally observed on the other spheres. Approximately 5 
microns underneath the thin layer of plates, a sponge like 




A IM  phosphate solution was prepared by dissolving an 
appropriate amount of sodium phosphate (Na2HP04) in 
de-ionized water along with 1.5 M HC1. After the sodium 
phosphate dissolved, 1.5 M tris (hydroxymethyl) ami- 
nomethane was added to raise the solution pH to 7.0.
The reactions of annealed 45SB1 glass microspheres with 
1 M phosphate at 37° C. were observed by optical micros­
copy until the microspheres had fully reacted to leave a 
microsphere with no unreacted glass core. To produce larger 
amounts of reacted microspheres for characterization, 
annealed 45SB1 microspheres were placed in the 1 M 
phosphate solution at a glass to solution ratio of 1 mg/ml, at 
a temperature of 37° C. After 1, 4,11, and 28 days at 37° C., 
microspheres were removed from the solution, dehydrated 
in a graded series of ethanol (80, 90, and 100%), and 
analyzed by SEM-EDS and XRD. The external surface of 
microspheres reacted for each time was examined by SEM, 
and the cross-section of microspheres from the one-day 
sample was examined by SEM-EDS. The microspheres 
were not heat treated after reacting with the phosphate 
solution.
Annealed 45S5 glass microspheres were reacted with 0.25 
M phosphate solution under the conditions described above. 
After 4, 14, and 28 days, microspheres were removed from 
the solution, and the external surfaces were examined by 
SEM. The reacted microspheres were also crushed with a 
mortar and pestle and analyzed by XRD. Only the external 
surface of microspheres reacted for each time was examined 
by SEM.
1 M and 0.25 M Na2HP04 solutions. Microspheres of 
45B5-1 glass immersed in the 1 M phosphate solution at 37° 
C. fully reacted in 24 hours, as shown in FIG. 8. The reaction 
product was a homogenous gel. FIG. 9 shows XRD patterns 
for annealed 45B5-1 microspheres that have been reacted 
with 1 M phosphate solution for 1, 4, and 11 days at 37° C., 
and the documented XRD pattern for HAp. These XRD 
patterns indicate the HAp is present along with residual 
amorphous material. Although it has been documented, that 
the crystallization of HAp on a glass surface is dependent on 
the presence of a silica gel layer, which serves as heteroge­
neous nucleation sites for HAp, these data suggest otherwise 
(since 45B5-1 glass contains no silica).
SEM Investigation
SEM-EDS indicated that the 45S5 microspheres that had 
reacted for one day with 1 M phosphate solution at 37° C. 
had a Ca:P ratio of 1.2, which is calcium deficient with 
respect to HAp (Ca:P=1.5 to 1.67). These results are con­
sistent with the XRD pattern, which showed the presence of 
some amorphous material, such as amorphous calcium phos­
phate (ACP), which usually has a Ca:P ratio ranging from 
1.2 to 1.5. The cross-sections of the 45B5-1 glass micro­
spheres reacted with 1 M phosphate for 24 hrs at 37° C. is 
shown in FIG. 10. Several of the microspheres shown in 
FIG. 10 have a dark spot in the center, which may contain 
a larger volume fraction PMMA than the rest of the micro­
sphere. The dark spot indicates that the reacted microspheres 
may have a lower density at the center than at the edges.
The external surfaces of 45B5-1 microspheres which have 
reacted with 1 M phosphate solution for 1, 4,11 and 28 days 
are shown in FIG. 11. After reacting for one day in 1 M 
phosphate solution, the surface of 45B5-1 is covered with 
needle-like and plate like crystals of HAp, with a size 
ranging from 5 by 100 nm to 10 by 200 nm. This crystal size 
and shape has also been reported as the structure of HAp 
precipitated from a solution and the apatitic component of 















visible after 4 days, but the crystals had grown outward from 
the surface to become more plate-like. The crystals also 
grew to approximately twice the length that they were after 
1 day of reaction with 1 M phosphate solution. After 11 days 
in 1 M phosphate solution, both needle-like and plate-like 
crystals appeared to be present. Only plate-like particles are 
visible after 28 days of reaction. Both needle-like and 
plate-like morphologies have been reported in the structure 
of the apatitic component of bone. However, the crystals 
formed by reactions longer than one day were larger than 
those present in natural bone, which are typically 40 by 20 
nm or smaller.
When 45S5 glass microspheres were reacted with the 0.25 
M phosphate solution at 37° C., for 14 and 28 days, XRD 
showed that HAp was present. The reaction layer on the 
particles was only -10 fim thick. A glassy core appeared in 
each microsphere, which accounts for the high background 
in the XRD pattern. The surface of 45S5 glass microspheres 
reacted with 0.25 M phosphate solution consisted of needle­
like HAp crystals. Microspheres reacted for 28 days, 
retained the needle-like structure seen after 14 days of 
reaction and the XRD pattern did not change significantly. 
This retention of structure differed from the reactions of 
45B5-1 glass with 1 M phosphate solution, where the 
morphology of the HAp crystals changed from needle-like 
to plate-like and the crystals grew.
Example—3
In Vivo Use
Prior to surgery, the glass powder was made as described 
in Example 1, and then stored in glass vials tightly covered 
with aluminum foil and heat sterilized at 450° C. in an 
electrical furnace for 3 hours. To promote the formation of 
a calcium phosphate rich layer on the surface of the bioac­
tive glass particles and to increase the formation rate of the 
new bone, the borate glass particles were pre-reacted for 24 
hours in 1 M Na2HP04 solution. The reacted surface layer 
that formed in 24 hours on the glass particles consisted of an 
amorphous calcium phosphate rich layer, with an average 
thickness, as determined by SEM, of 60 fim±20 and was 
identified as composed of needle-like or small (300-600 nm) 
plates standing nearly perpendicular to the surface of the 
glass. This platelike structure was very similar to the struc­
ture observed on particles reacted under the same conditions 
in 1 M K^HPC^ solutions.
45S5 silicate glass particles were obtained from Mo-Sci 
Corp. (Rolla, Mo.) and used in their as received state. After 
receipt, they were stored in glass vials tightly covered with 
aluminum foil and heat sterilized at 500° C. in an electrical 
furnace for 3 hours. Particles in the size range of 300-355 
micron were used for implantation. The particles of 45S5 
glass and particles of 45B5-1 glass were implanted in the 
upper part of the tibia of 12 mature male rats. The rats were 
anesthetized with a xylazine-ketamine mixture injected 
intraperitoneally. A 0.5 mm diameter dental drill, was used 
under phosphate buffered solution (PBS) irrigation, to make 
two holes in each tibia that penetrated into the bone marrow 
region. The resulting holes in the tibia of the rats were 
between 0.6 to 1.2 mm in diameter.
The glass particles were loosely packed in a glass capil­
lary tube 0.5 mm in diameter. Pressure applied on a plunger 
introduced in the capillary tube released the glass particles 
in the hole. Contact of the capillary tube with body fluids had 
to be avoided since the fluids would instantly wet the glass 
particles and prevent them from sliding out of the capillary 
tube hole.
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Once the particles were placed in the tibia hole, the wound 
was closed externally by staple-like metallic clips. All the 
rats survived the surgery, appeared healthy and showed no 
sign of post-surgery infection. The rats were sacrificed at 15, 
30, 45 and 60 days after implantation. The tibiae recovered 
from the rats were fixed in 4% formaldehyde, dehydrated in 
serial ethanol concentrations and embedded in polymethyl­
methacrylate (PMMA). At the site of each hole, the tibia was 
sectioned with a diamond saw, polished with 1 fim diamond 
paste and coated with a gold palladium film for examination 
in a Hitachi S-570 (Hitachi, Japan) or Jeol T330 A (Jeol, 
Japan) SEM.
Backscattered electron (BSE) imaging was used to deter­
mine the degree of bone growth for each implantation 
periods. In back-scattered mode, the light colored regions 
correspond to elements with a higher atomic number while 
the darker regions contain elements of lower atomic num­
bers. New bone generally had a medium to light gray color 
and un-mineralized calcium phosphate was a whiter, light 
gray color. Hie unreacted glassy core of the particles was a 
dark gray color.
Reaction of the Borate Glass Particles In Vivo
The 45B5-1 glass particles had a glassy, dark core in the 
center of the particles surrounded by a continuous layer. Uiis 
white layer was identified by EDS to be calcium phosphate 
rich with a calcium to phosphorus ratio of 1.45±0.1 
(stochiometric HAp has a Ca/P ratio of 1.67). XRD analysis 
revealed that the crystalline calcium phosphate rich layer, 
initially too thin to give any diffraction pattern, became 
detectable in as little as 11 days. Black lines drawn on some 
of the figures denote the edges of the initial hole in the tibia.
Reaction after 15 days. New bone formation (medium 
gray in color) was observed as early as 15 days around some 
particles (FIG. 12). New bone indicated by the arrows was 
also visible at the edge of the hole, even though the original 
hole was not completely filled at 15 days. The average 
thickness of the reacted surface layer on the 45B5-1 glass 
particles slightly increased from 60 ,Mn±20 to 80 fim±20. 
The particles of 45S5 glass and 45B5-1 glass seemed to stay 
in place at the edge of the cavity. The rapid formation of 
bone indicates that the pre-reacted surface is a suitable 
environment for bone bonding or growth.
Reaction after 30 days. After 30 days in vivo, both the 
45B5-1 (FIG. 13) and the 45S5 glass particles were largely 
in contact with new bone. A layer of porous new bone closed 
the hole in all cases. The reacted layer did not seem to 
increase in thickness around the 45S5 glass (approx. 30 to 50 
microns thick after 30 days in the rat). This surface layer was 
easily visible around the dark core of the 45S5 particles.
The unreacted core of the silica-free borate glass particles 
surrounded with new bone did not shrink. The thickness of 
the surface layer surrounding the 45B5-1 glass particles was 
still approximately 80 ,Mn±20 after 30 days, but the lighter 
surface layer on the borate particles had cracked and in some 
cases separated from the medium gray core.
In general, the new bone that had formed around the 
pre-reacted borate particles after 30 days appeared denser 
(with smaller pores) and thicker than the bone associated 
with the 45S5 glass particles. However, it should be recalled 
that even though the borate glass particles were pre-reacted 
before implantation, the calcium phosphate layer grown in 
vitro was only about 60 microns in thickness.
Reaction after 60 days. After 60 days in the rat, the holes 
were completely closed and it was often difficult to distin­
guish between the old and new bone. It was difficult to 
distinguish the residual core of the 45B5-1 glass particles, 
















particles (light gray) were surrounded by dense new bone. 
However, a dark core was still visible in many of the 45B5-1 
particles trapped in the marrow cavity.
Unlike the borate particles, the 45S5 glass particles sur­
rounded by new bone still contained a visible dark core most 
likely because they were not fully reacted after 60 days in 
vivo.
The foregoing specification is meant to illustrate the 
invention, and not limit it in any way. Those skilled in the 
art will recognize that modifications of little or great degree 
can be made which are within the spirit and scope of the 
many embodiments of this invention as defined in the 
appended claims.
What is claimed is:
1. A bioactive material having the formula
xNa20.yCa0.zP20 5.qB20 3
wherein x is from about 20% to about 35%; 
y is from about 20% to about 35%; 
z is from about 0% to about 10%; and 
q is from about 30% to about 50%.
2. The bioactive material of claim 1 wherein the material 
is ceramic.
3. The bioactive material of claim 1 wherein the material 
is glass.
4. The bioactive material of claim 1 wherein the material 
is glass-ceramic.
5. The bioactive material of claim 1 wherein the material 
is at least partially crystalline.
6. The bioactive material of claim 1 having a calcium 
phosphate surface layer thereupon.
7. The bioactive material of claim 6 wherein the calcium 
phosphate layer is hydroxyapatite.
8. The bioactive material of claim 1 which forms a 
calcium phosphate layer when in contact with a physiologi­
cal solution.
9. The bioactive material of claim 1 wherein x is from 
about 22% to about 30%, y is from about 22% to about 30%, 
z is from about 5% to about 6%, q is from about 35% to 
about 50%.
10. The bioactive material of claim 1 wherein x is about 
22.9%, y is about 22.9%, z is about 5.6% and q is about 
48.6%.
11. The bioactive material of claim 1 wherein the glass is 
comprised of particles.
12. A particulate borate ceramic, the particles of the 
ceramic being at least a partial calcium phosphate layer 
thereupon.
13. A process for providing a bioactive material compris­
ing reac t ing  a ma te r i a l  hav i ng  the formula  
xNa20.yCa0.zP20 5.qB20 3:
wherein x is from about 20% to about 35%; 
y is from about 20% to about 35%; 
z is from about 0% to about 10%; and 
q is from about 30% to about 50%; 
with an aqueous solution comprising phosphate ions for a 
time sufficient to form calcium phosphate upon said mate­
rial.
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14. The process of claim 13 wherein the material is 
ceramic.
15. The process of claim 13 wherein the material is glass.
16. The process of claim 13 wherein the material is 
glass-ceramic.
17. The process of claim 13 wherein x is from about 22% 
to about 30%, y is from about 22% to about 30%, z is from 
about 5% to about 6%, q is from about 35% to about 50%.
18. The process of claim 13 wherein x is about 22.9%, y 
is about 22.9%, z is about 5.6% and q is about 48.6%.
19. The process of claim 13 wherein the aqueous solution 
is Na2HP04.
20. The process of claim 13 wherein the aqueous solution 
is iqHPCy.
21. The process of claim 13 wherein the phosphate 
solution has a concentration of about 0.001 M to about 1 M.
22. The process of claim 21 wherein the phosphate 
solution has a concentration of about 0.01 M to about 0.25 
M.
23. The process of claim 13 wherein the initial pH is in the 
range of about 6 to about 10 .
24. The process of claim 23 wherein the initial pH is about 
7.
25. The process of claim 13 wherein the temperature is in 
the range of about 30° C. to about 60° C.
26. The process of claim 25 wherein the temperature is 
about 35° C. to about 57° C.
27. The process of claim 13 wherein the temperature is 
about 37° C.
28. The process of claim 13 wherein said time is from 
about 4 hours to about 14 days.
29. The process of claim 28 wherein the time is from 
about 5 days to about 14 days.
30. The process of claim 13 wherein the time is about 24 
hours.
31. The process of claim 13 wherein the material is 
comprised of particles.
32. The process of claim 31 wherein the glass has a 
particle size range from about 1 fim to about 400 fim.
33. The process of claim 32 wherein the glass has a 
particle size range from about 40 fim to about 300 fim.
34. The process of claim 33 wherein the glass has a 
particle size range from about 60 fim to about 250 fim.
35. The process of claim 13 wherein the glass has a 
particle size range from about 75 fim up to about 1 mm.
36. The process of claim 13 wherein the material is 
generally spherical.
37. The process of claim 13 wherein the material is in 
morsel form.
38. The process of claim 13 wherein the material is in bulk 
form.
39. The process of claim 13 wherein the material is 
fibrous.
40. The process of claim 13 wherein the material is 
foliaceous.
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